Negligible Genetic Diversity of Mycobacterium Tuberculosis Host Immune System Protein Targets: Evidence of Limited Selective Pressure
Overview
Authors
Affiliations
A common theme in medical microbiology is that the amount of amino acid sequence variation in proteins that are targets of the host immune system greatly exceeds that found in metabolic enzymes or other housekeeping proteins. Twenty-four Mycobacterium tuberculosis genes coding for targets of the host immune system were sequenced in 16 strains representing the breadth of genomic diversity in the species. Of the 24 genes, 19 were invariant and only six polymorphic nucleotide sites were identified in the 5 genes that did have variation. The results document the highly unusual circumstance that prominent M. tuberculosis antigenic proteins have negligible structural variation worldwide. The data are best explained by a combination of three factors: (i) evolutionarily recent global dissemination in humans, (ii) lengthy intracellular quiescence, and (iii) active replication in relatively few fully immunocompetent hosts. The very low level of amino acid diversity in antigenic proteins may be cause for optimism in the difficult fight to control global tuberculosis.
Host-directed immunotherapy of viral and bacterial infections: past, present and future.
Wallis R, OGarra A, Sher A, Wack A Nat Rev Immunol. 2022; 23(2):121-133.
PMID: 35672482 PMC: 9171745. DOI: 10.1038/s41577-022-00734-z.
Whole-Genome Sequencing of Two Moroccan Mycobacterium tuberculosis Strains.
Laamarti M, El Mrimar N, Alouane T, Kartti S, Belouad E, Bssaibis F Microbiol Resour Announc. 2021; 10(1).
PMID: 33414280 PMC: 8407682. DOI: 10.1128/MRA.00635-20.
Dixit A, Freschi L, Vargas R, Calderon R, Sacchettini J, Drobniewski F Sci Rep. 2019; 9(1):5602.
PMID: 30944370 PMC: 6447560. DOI: 10.1038/s41598-019-41967-8.
Antigenic Variation and Immune Escape in the MTBC.
Ernst J Adv Exp Med Biol. 2017; 1019:171-190.
PMID: 29116635 PMC: 5718154. DOI: 10.1007/978-3-319-64371-7_9.
Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
Mnyambwa N, Kim D, Ngadaya E, Kazwala R, Petrucka P, Mfinanga S Eur J Clin Microbiol Infect Dis. 2017; 36(11):2021-2028.
PMID: 28593375 DOI: 10.1007/s10096-017-3027-3.